The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort
Osteoarthritis and Cartilage Jan 29, 2020
Garnero P, et al. - A 18-year evaluation of the OFELY prospective cohort was conducted to evaluate the correlation of urinary CTX-II, a biochemical marker of cartilage breakdown, with the risk of total joint replacement (TJR). They examined a sum of 478 postmenopausal women (mean age 65.5±7.5 yr.) including from the OFELY cohort. They assessed CTX-II, serum CTX-I (bone resorption) and PINP (bone formation), at baseline. They measured the correlation between CTX-II and incidence of TJR by Cox Hazard Regression. Thirty-eight women sustained a TJR, including hip or knee replacement during a median 17.8 years follow-up. They found higher CTX-II -but not CTX-I or PINP- in individuals with TJR. In postmenopausal women, CTX-II is an independent risk indicator of TJR suggesting that it may be useful to distinguish subjects at high risk of TJR.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries